Tanja Falter

641 total citations
26 papers, 384 citations indexed

About

Tanja Falter is a scholar working on Immunology, Hematology and Nephrology. According to data from OpenAlex, Tanja Falter has authored 26 papers receiving a total of 384 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Immunology, 8 papers in Hematology and 5 papers in Nephrology. Recurrent topics in Tanja Falter's work include Complement system in diseases (14 papers), Platelet Disorders and Treatments (7 papers) and Renal Diseases and Glomerulopathies (5 papers). Tanja Falter is often cited by papers focused on Complement system in diseases (14 papers), Platelet Disorders and Treatments (7 papers) and Renal Diseases and Glomerulopathies (5 papers). Tanja Falter collaborates with scholars based in Germany, Switzerland and United States. Tanja Falter's co-authors include Gudrun Hefner, Christoph Hiemke, Karl J. Lackner, Stefan Unterecker, Mohamed E. E. Shams, Bernhard Lämmle, Charis von Auer, Nadine Müller‐Calleja, Wolfram Ruf and Stefanie Wagner and has published in prestigious journals such as Blood, Psychopharmacology and Thrombosis and Haemostasis.

In The Last Decade

Tanja Falter

24 papers receiving 379 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tanja Falter Germany 11 149 92 73 59 59 26 384
Concepción González Spain 15 82 0.6× 23 0.3× 10 0.1× 18 0.3× 34 0.6× 34 533
Nobuyoshi Sugiyama Japan 10 38 0.3× 50 0.5× 104 1.4× 9 0.2× 78 1.3× 28 342
Núria Serra Spain 11 40 0.3× 17 0.2× 57 0.8× 11 0.2× 21 0.4× 19 363
Marla Hochfeld United States 6 266 1.8× 154 1.7× 12 0.2× 5 0.1× 114 1.9× 8 532
Michela Mariani Italy 8 77 0.5× 34 0.4× 4 0.1× 49 0.8× 86 1.5× 26 414
Klaus Krueger Germany 9 69 0.5× 112 1.2× 5 0.1× 23 0.4× 14 0.2× 21 565
Sara Bongiovanni Italy 10 60 0.4× 27 0.3× 7 0.1× 22 0.4× 81 1.4× 22 323
Elaine Regina Delicato de Almeida Brazil 12 83 0.6× 33 0.4× 4 0.1× 7 0.1× 39 0.7× 24 482
Uttam Kumar Nath India 12 42 0.3× 96 1.0× 7 0.1× 125 2.1× 34 0.6× 65 575
Nailú Angélica Sinicato Brazil 11 169 1.1× 20 0.2× 14 0.2× 5 0.1× 12 0.2× 22 392

Countries citing papers authored by Tanja Falter

Since Specialization
Citations

This map shows the geographic impact of Tanja Falter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tanja Falter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tanja Falter more than expected).

Fields of papers citing papers by Tanja Falter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tanja Falter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tanja Falter. The network helps show where Tanja Falter may publish in the future.

Co-authorship network of co-authors of Tanja Falter

This figure shows the co-authorship network connecting the top 25 collaborators of Tanja Falter. A scholar is included among the top collaborators of Tanja Falter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tanja Falter. Tanja Falter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Häuser, Friederike, Jens Mittler, Oliver Kriege, et al.. (2023). One fits all: a highly sensitive combined ddPCR/pyrosequencing system for the quantification of microchimerism after hematopoietic and solid organ transplantation. Clinical Chemistry and Laboratory Medicine (CCLM). 61(11). 1994–2001.
2.
Falter, Tanja, Anita M. Hennige, Andreas Schulz, et al.. (2023). Prevalence of Overweight and Obesity, Its Complications, and Progression in a 10-Year Follow-Up in the Gutenberg Health Study (GHS). Obesity Facts. 17(1). 12–23. 4 indexed citations
3.
Falter, Tanja, Heidi Rossmann, Charis von Auer, et al.. (2023). A novel von Willebrand factor multimer ratio as marker of disease activity in thrombotic thrombocytopenic purpura. Blood Advances. 7(17). 5091–5102. 5 indexed citations
4.
Sakai, Kazuya, Ilaria Mancini, György Sinkovits, et al.. (2023). Open ADAMTS-13 conformation index predicts earlier relapse in immune-mediated thrombotic thrombocytopenic purpura. Journal of Thrombosis and Haemostasis. 22(2). 493–502. 7 indexed citations
5.
Müller‐Calleja, Nadine, Antje Canisius, Martin F. Sprinzl, et al.. (2021). Pathogenic lipid‐binding antiphospholipid antibodies are associated with severity of COVID‐19. Journal of Thrombosis and Haemostasis. 19(9). 2335–2347. 29 indexed citations
7.
Schulz, Andreas, Thomas Koeck, Tanja Falter, et al.. (2021). Distribution of HOMA-IR in a population-based cohort and proposal for reference intervals. Clinical Chemistry and Laboratory Medicine (CCLM). 59(11). 1844–1851. 21 indexed citations
8.
Hobohm, Lukas, Michael Reuter, Visvakanth Sivanathan, et al.. (2021). COVID-19 as a Potential Trigger for Immune Thrombotic Thrombocytopenic Purpura and Reason for an Unusual Treatment: A Case Report. Hämostaseologie. 43(3). 215–218. 2 indexed citations
10.
Schmidtmann, Irene, Leon A. Bach, Tanja Falter, et al.. (2019). Eleven Relapses in a Cohort of 78 Patients with Immune Thrombotic Thrombocytopenic Purpura (iTTP): Data from the German TTP-Registry. Hämostaseologie. 1 indexed citations
11.
Müller‐Calleja, Nadine, et al.. (2018). Complement C5 but not C3 is expendable for tissue factor activation by cofactor-independent antiphospholipid antibodies. Blood Advances. 2(9). 979–986. 38 indexed citations
12.
Lieb, Klaus, Nadine Dreimüller, Stefanie Wagner, et al.. (2018). BDNF Plasma Levels and BDNF Exon IV Promoter Methylation as Predictors for Antidepressant Treatment Response. Frontiers in Psychiatry. 9. 511–511. 39 indexed citations
13.
Falter, Tanja, Veronika Weyer‐Elberich, Charis von Auer, et al.. (2018). Relapse Rate in Survivors of Acute Autoimmune Thrombotic Thrombocytopenic Purpura Treated with or without Rituximab. Thrombosis and Haemostasis. 118(10). 1743–1751. 28 indexed citations
14.
Falter, Tanja, Veronika Weyer, Charis von Auer, et al.. (2017). Depression and cognitive deficits as long‐term consequences of thrombotic thrombocytopenic purpura. Transfusion. 57(5). 1152–1162. 40 indexed citations
15.
Hefner, Gudrun, Mohamed E. E. Shams, Stefan Unterecker, Tanja Falter, & Christoph Hiemke. (2015). Inflammation and psychotropic drugs: the relationship between C-reactive protein and antipsychotic drug levels. Psychopharmacology. 233(9). 1695–1705. 62 indexed citations
16.
Hefner, Gudrun, Stefan Unterecker, Mohamed E. E. Shams, et al.. (2015). Melperone but not bisoprolol or metoprolol is a clinically relevant inhibitor of CYP2D6: evidence from a therapeutic drug monitoring survey. Journal of Neural Transmission. 122(11). 1609–1617. 9 indexed citations
17.
Hefner, Gudrun, Katharina Wenzel‐Seifert, Andreas Fellgiebel, et al.. (2015). Rating The Delirogenic Potential of Drugs for Prediction of Side Effects in Elderly Psychiatric Inpatients. 10 indexed citations
18.
Hovinga, Johanna A. Kremer, et al.. (2014). Late onset and pregnancy-induced congenital thrombotic thrombocytopenic purpura. Hämostaseologie. 34(3). 244–248. 5 indexed citations
19.
Falter, Tanja, et al.. (2013). Long term outcome and sequelae in patients after acute thrombotic thrombocytopenic purpura episodes. Hämostaseologie. 33(2). 113–120. 15 indexed citations
20.
Falter, Tanja, et al.. (2010). Evaluation of Clotting Factor Concentrates for Treatment of Thrombotic Thrombocytopenic Purpura.. Blood. 116(21). 3678–3678. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026